Related stories
The big winners of the tech wreck are biopharma stocks
Anthropic may not secure investment-grade rating after IPO, Blackstone says
After Intel’s historic stock drop, analysts say there’s no reason to buy the dip
CD&R pursues buyout of $40bn card processor Global Payments
Trump administration is illegally delaying student-debt forgiveness for tens of thousands of public servants, lawsuit alleges
Private equity in your 401(k)? Heed Warren Buffett’s warning.